These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13526191)

  • 21. Calreticulin exposure is required for the immunogenicity of gamma-irradiation and UVC light-induced apoptosis.
    Obeid M; Panaretakis T; Joza N; Tufi R; Tesniere A; van Endert P; Zitvogel L; Kroemer G
    Cell Death Differ; 2007 Oct; 14(10):1848-50. PubMed ID: 17657249
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiation injuries of the lungs and the pleura in x-ray and gamma ray therapy of breast cancer].
    RABINOVICH RM; KANTIN AV
    Vopr Onkol; 1957; 3(6):711-9. PubMed ID: 13530847
    [No Abstract]   [Full Text] [Related]  

  • 23. Combined therapy using suicide gef gene and paclitaxel enhances growth inhibition of multicellular tumour spheroids of A-549 human lung cancer cells.
    Prados J; Melguizo C; Rama A; Ortiz R; Boulaiz H; Rodriguez-Serrano F; Caba O; Rodriguez-Herva JJ; Ramos JL; Aranega A
    Int J Oncol; 2008 Jul; 33(1):121-7. PubMed ID: 18575757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Augmented antitumor effects of radiation therapy by 4-1BB antibody (BMS-469492) treatment.
    Shi W; Siemann DW
    Anticancer Res; 2006; 26(5A):3445-53. PubMed ID: 17094465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of non small cell lung cancer].
    Skricková J; Coupek P; Babicková L; Tomísková M; Kaplanová J; Princ D; Kadlec B; Spelda S
    Klin Onkol; 2008; 21(6):317-29. PubMed ID: 19382595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection of gamma-ray emitting isotopes as permanent implants in the treatment of cancer.
    COHEN L
    Phys Med Biol; 1958 Jan; 2(3):229-33. PubMed ID: 13517948
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of lung cancer].
    Ostoros G
    Orv Hetil; 2004 Jan; 145(1):33-4. PubMed ID: 15222139
    [No Abstract]   [Full Text] [Related]  

  • 28. Trimodal therapy for histologically proven N2/3 non-small cell lung cancer: mid-term results and indicators for survival.
    Steger V; Walles T; Kosan B; Walker T; Kyriss T; Veit S; Dippon J; Friedel G
    Ann Thorac Surg; 2009 Jun; 87(6):1676-83. PubMed ID: 19463576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [It is still coming: molecular-targeted therapy of lung cancer].
    Huber RM; Gamarra F
    Pneumologie; 2005 May; 59(5):309-10. PubMed ID: 15902594
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular staging and the selection of therapy for non-small cell lung cancer.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):180-5. PubMed ID: 16253819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dosimetric characteristics of GUTCo-400-1 gamma-ray apparatus].
    NEVSKAIA GF
    Vestn Rentgenol Radiol; 1959; 34(2):63-7. PubMed ID: 13669263
    [No Abstract]   [Full Text] [Related]  

  • 32. [Therapeutic gamma-ray apparatus; aid to a general practitioner].
    VAINBERG MSh
    Vestn Rentgenol Radiol; 1959; 34(2):56-62. PubMed ID: 13669262
    [No Abstract]   [Full Text] [Related]  

  • 33. Current status of gene therapy for lung cancer and head and neck cancer.
    Moon C; Oh Y; Roth JA
    Clin Cancer Res; 2003 Nov; 9(14):5055-67. PubMed ID: 14613982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapy of lung cancer].
    Fischer B; Buhl R
    Pneumologie; 2005 Nov; 59(11):783-97; quiz 798-803. PubMed ID: 16385440
    [No Abstract]   [Full Text] [Related]  

  • 35. A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S; Nagato K; Kunii N; Yamamoto H; Yamasaki K; Okita K; Hanaoka H; Shimizu N; Suzuki M; Yoshino I; Taniguchi M; Fujisawa T; Nakayama T
    J Immunol; 2009 Feb; 182(4):2492-501. PubMed ID: 19201905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer.
    Kakimi K; Nakajima J; Wada H
    Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Invited commentary. The role of tri-modality therapy in stage III nonsmall cell lung cancer (NSCLC) is highly controversial.
    Kodama K
    Ann Thorac Surg; 2008 Sep; 86(3):910-1. PubMed ID: 18721581
    [No Abstract]   [Full Text] [Related]  

  • 38. Supportive care in lung cancer.
    Boyar M; Raftopoulos H
    Hematol Oncol Clin North Am; 2005 Apr; 19(2):369-87, vii. PubMed ID: 15833411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer.
    Neville A
    Clin Evid; 2003 Dec; (10):1804-23. PubMed ID: 15555176
    [No Abstract]   [Full Text] [Related]  

  • 40. Adjuvant therapies for non-small cell lung cancer: introduction.
    D'Amico TA
    Semin Thorac Cardiovasc Surg; 2005; 17(3):179. PubMed ID: 16253818
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.